335 related articles for article (PubMed ID: 3928681)
1. Virulence of Cryptococcus neoformans. Regulation of capsule synthesis by carbon dioxide.
Granger DL; Perfect JR; Durack DT
J Clin Invest; 1985 Aug; 76(2):508-16. PubMed ID: 3928681
[TBL] [Abstract][Full Text] [Related]
2. Regulation of cryptococcal capsular polysaccharide by iron.
Vartivarian SE; Anaissie EJ; Cowart RE; Sprigg HA; Tingler MJ; Jacobson ES
J Infect Dis; 1993 Jan; 167(1):186-90. PubMed ID: 8418165
[TBL] [Abstract][Full Text] [Related]
3. Cryptococcus neoformans senses CO2 through the carbonic anhydrase Can2 and the adenylyl cyclase Cac1.
Mogensen EG; Janbon G; Chaloupka J; Steegborn C; Fu MS; Moyrand F; Klengel T; Pearson DS; Geeves MA; Buck J; Levin LR; Mühlschlegel FA
Eukaryot Cell; 2006 Jan; 5(1):103-11. PubMed ID: 16400172
[TBL] [Abstract][Full Text] [Related]
4. Secretion of the C3 component of complement by peritoneal cells cultured with encapsulated Cryptococcus neoformans.
Blackstock R; Murphy JW
Infect Immun; 1997 Oct; 65(10):4114-21. PubMed ID: 9317016
[TBL] [Abstract][Full Text] [Related]
5. Role of the capsule in phagocytosis of Cryptococcus neoformans.
Kozel TR; Pfrommer GS; Guerlain AS; Highison BA; Highison GJ
Rev Infect Dis; 1988; 10 Suppl 2():S436-9. PubMed ID: 3055212
[TBL] [Abstract][Full Text] [Related]
6. Paradoxical role of capsule in murine bronchoalveolar macrophage-mediated killing of Cryptococcus neoformans.
Levitz SM; DiBenedetto DJ
J Immunol; 1989 Jan; 142(2):659-65. PubMed ID: 2521352
[TBL] [Abstract][Full Text] [Related]
7. Capsule size of Cryptococcus neoformans: control and relationship to virulence.
Dykstra MA; Friedman L; Murphy JW
Infect Immun; 1977 Apr; 16(1):129-35. PubMed ID: 326665
[TBL] [Abstract][Full Text] [Related]
8. Role of serum factors in the phagocytosis of weakly or heavily encapsulated Cryptococcus neoformans strains by guinea pig peripheral blood leukocytes.
Ikeda R; Shinoda T; Kagaya K; Fukazawa Y
Microbiol Immunol; 1984; 28(1):51-61. PubMed ID: 6374392
[TBL] [Abstract][Full Text] [Related]
9. Influence of molecular sizes of Cryptococcus neoformans capsular polysaccharide on phagocytosis.
Yasuoka A; Kohno S; Yamada H; Kaku M; Koga H
Microbiol Immunol; 1994; 38(11):851-6. PubMed ID: 7898383
[TBL] [Abstract][Full Text] [Related]
10. The Capsule of Cryptococcus neoformans Modulates Phagosomal pH through Its Acid-Base Properties.
De Leon-Rodriguez CM; Fu MS; Çorbali MO; Cordero RJB; Casadevall A
mSphere; 2018 Oct; 3(5):. PubMed ID: 30355667
[TBL] [Abstract][Full Text] [Related]
11. Capsule enlargement in Cryptococcus neoformans confers resistance to oxidative stress suggesting a mechanism for intracellular survival.
Zaragoza O; Chrisman CJ; Castelli MV; Frases S; Cuenca-Estrella M; Rodríguez-Tudela JL; Casadevall A
Cell Microbiol; 2008 Oct; 10(10):2043-57. PubMed ID: 18554313
[TBL] [Abstract][Full Text] [Related]
12. Cryptococcus neoformans. 3. Inhibition of phagocytosis.
Bulmer GS; Sans MD
J Bacteriol; 1968 Jan; 95(1):5-8. PubMed ID: 4866104
[TBL] [Abstract][Full Text] [Related]
13. Phagocytosis and killing of Cryptococcus neoformans by rat alveolar macrophages in the absence of serum.
Bolaños B; Mitchell TG
J Leukoc Biol; 1989 Dec; 46(6):521-8. PubMed ID: 2681492
[TBL] [Abstract][Full Text] [Related]
14. The capsule of cryptococcus neoformans passively inhibits phagocytosis of the yeast by macrophages.
Kozel TR; Gotschlich EC
J Immunol; 1982 Oct; 129(4):1675-80. PubMed ID: 7050244
[TBL] [Abstract][Full Text] [Related]
15. Cryptococcus neoformans responds to mannitol by increasing capsule size in vitro and in vivo.
Guimarães AJ; Frases S; Cordero RJ; Nimrichter L; Casadevall A; Nosanchuk JD
Cell Microbiol; 2010 Jun; 12(6):740-53. PubMed ID: 20070311
[TBL] [Abstract][Full Text] [Related]
16. Strain variation in antiphagocytic activity of capsular polysaccharides from Cryptococcus neoformans serotype A.
Small JM; Mitchell TG
Infect Immun; 1989 Dec; 57(12):3751-6. PubMed ID: 2680980
[TBL] [Abstract][Full Text] [Related]
17. Characterization of pathogenic constituents of Cryptococcus neoformans strains.
Kagaya K; Yamada T; Miyakawa Y; Fukazawa Y; Saito S
Microbiol Immunol; 1985; 29(6):517-32. PubMed ID: 3900645
[TBL] [Abstract][Full Text] [Related]
18. Virulence, capsule size and lipid composition interrelation of Cryptococcus neoformans.
Upreti HB; Rawat DS; Das SK
Microbiologica; 1984 Oct; 7(4):371-4. PubMed ID: 6392831
[TBL] [Abstract][Full Text] [Related]
19. The Buoyancy of
Vij R; Cordero RJB; Casadevall A
mSphere; 2018 Nov; 3(6):. PubMed ID: 30404928
[No Abstract] [Full Text] [Related]
20. Scanning electron microscopy of encapsulated and non-encapsulated Cryptococcus neoformans and the effect of glucose on capsular polysaccharide release.
Cleare W; Casadevall A
Med Mycol; 1999 Aug; 37(4):235-43. PubMed ID: 10421858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
